Feto-Maternal Safety of Intracervical Sodium Nitroprusside Application in Sheep

Abstract

The feto-maternal safety of sodium nitroprusside (SNP) administration in the cervix of pregnant sheep is evaluated. Chronically catheterized pregnant sheep at ∼0.9 gestation were divided into 2 groups that received 0.1 mg/kg maternal body weight of SNP gel (2%) or placebo into the internal cervical os. SNP or placebo gel was administered at 9 AM with both maternal and fetal blood gas/pH, and cardiovascular parameters were monitored for 6 hours. Except for a slight transient decrease of maternal oxygen and meta-hemoglobin content, and fetal oxygen content in the SNP group, no other significant changes were observed. However, such changes are minimal and unlikely to be of any clinical significance. Moreover, nitric oxide metabolites were unchanged in both maternal and fetal circulations.These data demonstrate few, if any, effects of intrauterine SNP administration on both cellular oxygenation and cardiovascular indexes. Thus, SNP treatment, once applied into the cervix, could be considered a safe procedure.

Keywords

Sodium nitroprusside fetal safety cervical ripening labor induction.

Get full access to this article

View all access options for this article.

References

Thomson AJ , Lunan CB , Ledingham M. , et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first three-month period termination of pregnancy . Lancet. 1998;352:1093-1096.

Facchinetti F. , Piccinini F. , Volpe A. Chemical ripening of the cervix with intracervical application of sodium nitroprusside: a randomized controlled trial. Hum Reprod. 2000;15:2224-2227.

Chanrachakul B. , Herabutya Y. , Punyavachira P. Randomized comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstet Gynecol. 2000;96:549-553.

Ekerhovd E. , Bullarbo M. , Andersch B. , Norström A. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study. Am J Obstet Gynecol. 2003;189:1692-1697.

Li I. , Chan C. , Ho PC A comparison of isosorbide moninitrate and misoprostol cervical ripening before suction evacuation. Obstet Gynecol. 2003;102:583-588.

Li I. , Chan C. , Ho PC A study of the effectiveness of cervical ripening with nitric oxide donor versus placebo for cervical priming before second three-month period termination of pregnancy. Contraception. 2003;68:269-272.

Bates CD , Nicoll AE , Mullen AB , Mackenzie F. , Thomson AJ , Norman JE Serum profile of isosorbide moninitrate after vaginal administration in the third trimester. BJOG. 2003; 110:64-67.

Troncoso GA , Villegas-Alvarado A. , Belmont-Gomez A. , Martinez-Herrera FJ , Villagrana-Zesati R. , Guerra-Infante F. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical effectiveness and safety prior to first three-month period surgical evacuation of retained products of conception. BJOG. 2005;112:1615-1619.

Piccinini F. , Fano A. , Volpe A. , Facchinetti F. Ripening of the cervix with sodium nitroprusside in nonpregnant women. J Soc Gynecol Investig. 2003;10:438-442.

10.

Osman I. , MacKenzie F. , Norrie J. , Murray HM , Greer IA , Norman JE The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol. 2006;194:1012-1021.

11.

Wölfler MM , Facchinetti F. , Venturini P. , et al. Induction of labor at term using isosorbide mononitrate simultaneously with dinoprostone compared to dinoprostone treatment alone: a randomized, controlled trial. Am J Obstet Gynecol. 2006 ;195:1617-1622.

12.

Lancaster J Jr , ed. Nitric Oxide: Principles and Actions. Sandiego, CA: Academic Press; 1996.

13.

Servent D. , Delaforge M. , Ducrocq C. , Mansuy D. , Lenfant M. Nitric oxide formation during microsomal hepatic denitration of glyceril trinitrate: involvement of cytocrome P-450. Biochem Biophys Res Commun . 1989;163:1210-1216.

14.

Naulty J. , Cefalo RC , Lewis PE Fetal toxicity of nitroprusside in the pregnant ewe. Am J Obstet Gynecol. 1981;139:708-711.

15.

Ellis SC , Wheeler AS , James FM III , et al. Fetal and maternal effects of sodium nitroprusside used to counteract hypertension in gravid ewes. Am J Obstet Gynecol. 1982;60:766-770.

16.

Wheeler AS , James FM III , Meis PJ , et al. Effects of nitroglycerin and nitroprusside on the uterine vasculature of gravid ewes. Anesthesiology. 1980:52:390-394.

17.

Page IH , Corcoran AC , Dustan HP , Koppanyi T. Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation. 1955;11:188-198.

18.

Eppel W. , Facchinetti F. , Schleussner E. , Pizzi C. , Gruber DM , et al. Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: a double-blind randomized, placebo-controlled multicenter trial. Am J Obstet Gynecol. 2005 ;192:856-861.

19.

Shoemaker CT , Meyers M. Sodium nitroprusside for control of severe hypertensive disease of pregnancy: a case report and discussion of potential toxicity. Am J Obstet Gynecol. 1984; 149:171-173.